Lam Le

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 304 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Alicia T. Widge, Amelia R. Hofstetter, Katherine V. Houser et al. · Science Translational Medicine · 2023 · 96 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Tracy J. Ruckwardt, Kaitlyn M. Morabito, Emily Phung et al. · The Lancet Respiratory Medicine · 2021 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions

Fin Milder, Mandy Jongeneelen, Tina Ritschel et al. · Proceedings of the National Academy of Sciences · 2022 · 59 citations · Full text

Life Sciences, Immunology, Molecular Biology +16